Metallo beta lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii

Indian Journal of Medical Microbiology

Volumn 29, Issue 3, 2011, Pages 302-304

  John, S ^a   Balagurunathan, R ^b  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b PERIYAR UNIVERSITY   (India)

Author keywords

Metallo b lactamases; MIC of meropenem; zinc substitution

Indexed keywords

CARBAPENEM DERIVATIVE; EDETIC ACID; MEROPENEM; METALLO BETA LACTAMASE; ZINC;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BROTH DILUTION; DISK DIFFUSION; ENZYME SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 80052615713     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.83918     Document Type: Article

References (12)

1. Tamilselvi A, Mugesh G, Nethaji M. "Antibiotic Resistance: Mono- and Dinuclear Zinc Complexes as Metallo - Lactamase Mimics". Chemistry 2006;12:7797-806. (Pubitemid 44625778)
2. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo beta lactamases: The quiet before storm? Clin Microbiol Rev 2005;18:306-25.
3. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad spectrum betaβ-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78.
4. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem - EDTA disk method for differentiation of metallo beta lactamases producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002;40:3798-801.
5. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA disk synergy test to screen metallo beta lactamases producing strains of Pseudomonas spp and Acinetobacter spp. Clin Microbiol Infect 2001;7:88-91. (Pubitemid 34960278)
6. National committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. 5th ed. NCCLS document M7-A5. Wayne, PA: NCCLS; 2000.
7. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare. Clin Infect Dis 2002;34:634-40. (Pubitemid 34165326)
8. Lone R, Shah A, Kadri SM, Lone S, Shah F. Nosocomial Multi-Drug-Resistant Acinetobacter Infections - Clinical Findings, Risk Factors and Demographic Characteristics. Bangladesh J Med Microbiol 2009;3:34-8.
9. Shete VB, Ghadage DP, Muley VA, Bhore AV. Acinetobacter septicemia in neonates admitted to intensive care units. J Lab Physicians 2009;1:73-6.
10. Bergogne-Brzin E, Towner KJ. Acinetobacter spp as nosocomial pathogens: Microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996;9:148-65. (Pubitemid 26123943)
11. Rizvi M, Fatima N, Rashid M, Shukla I, Malik A, Usman A, et al. Extended spectrum AmpC and metallo beta lactamase in Serratia and Citrobacter spp in a disc approximation assay. J Infect Dev Ctries 2009;3:285-94.
12. Afzal-Shah M, Livermore DM. Worldwide emergence of Carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother 1998;41:576-7. (Pubitemid 28230316)